A multicenter, randomized clinical trial comparing zoledronic acid versus observation in patients with asymptomatic myeloma-Reference-Cited by-同舟云学术

A multicenter, randomized clinical trial comparing zoledronic acid versus observation in patients with asymptomatic myeloma

Published:2008-10-01 Issue:7 Volume:113 Page:1588-1595
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Musto Pellegrino,Petrucci Maria Teresa,Bringhen Sara,Guglielmelli Tommasina,Caravita Tommaso,Bongarzoni Velia,Andriani Alessandro,D'Arena Giovanni,Balleari Enrico,Pietrantuono Giuseppe,Boccadoro Mario,Palumbo Antonio,

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference51 articles.

1. Clinical course and prognosis in smoldering (asymptomatic) multiple myeloma;Kyle;N Engl J Med.,2007

2. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group;International Myeloma Working Group;Br J Haematol.,2003

3. Early versus deferred treatment for early stage multiple myeloma;He;Cochrane Database Syst Rev.,2003

4. Initial versus deferred melphalan-prednisone therapy for asymptomatic multiple myeloma stage I: a randomized study;Hjorth;Eur J Haematol.,1993

Cited by 161 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating early intervention in smoldering myeloma clinical trials: a systematic review;The Oncologist;2024-09-05

2. Monoclonal Antibodies in Smoldering Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance: Current Status and Future Directions;Pharmaceuticals;2024-07-06

3. Risk stratification models overestimate progression risk in contemporary patients with smoldering multiple myeloma;HemaSphere;2024-03

4. Diagnosis and management of smouldering myeloma: A British Society for Haematology Good Practice Paper;British Journal of Haematology;2024-02-23

5. Elucidation of molecular basis of osteolytic bone lesions in advanced multiple myeloma;Haematologica;2024-01-11